author-photo

Nancy L. Samberg

Center for Global Development

4

Papers

31

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies

2016 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (27)
A Phase 1 Dose‐Escalation Study of ASP2409, a Selective T‐Cell Costimulation Inhibitor, in Stable Rheumatoid Arthritis Patients on Methotrexate Therapy

2016 Clinical pharmacology in drug development
Show All
- Source
- Cite
- Save
Citations (2)
Abstract B187: Pharmacodynamics of OSI-027, a dual mTORC1/mTORC2 inhibitor, in tumor and surrogate tissues: Results from the expansion phase of a first-in-man study.

2013 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (1)